ProMetic raises $30 million

Canada's ProMetic Life Sciences has raised $30 million in debt financing from Structured Alpha LP, an affiliate of Peter J. Thomson's investment firm, Thomvest Asset Management. Thomson's investment firm has now invested $60 million in ProMetic. The biotech offers a range of services, including large-scale purification of biologics, drug development, proteomics and the elimination of pathogens. Release

Suggested Articles

The ambitious target is enabled by an AI discovery platform that Healx thinks gives it a scalability that has more in common with tech than biotech.

Eli Lilly is closing down its U.K.-based Erl Wood neuroscience in Surrey, leading to cuts and relocations.

After being hailed as a near mystic when it came to stock picks, Britain’s once great oak has been cut down to a sapling as Neil Woodford gets the ax.